ITGA7
Integrin alpha-7
Also known as: ITA7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13683
- Gene
- ITGA7
- Ensembl
- ENSG00000135424
- Chromosome
- 12
- Canonical length
- 1181 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Nuclear speckles,Vesicles,Plasma membrane
OverviewNCBI Gene
The protein encoded by this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. They mediate a wide spectrum of cell-cell and cell-matrix interactions, and thus play a role in cell migration, morphologic development, differentiation, and metastasis. This protein functions as a receptor for the basement membrane protein laminin-1. It is mainly expressed in skeletal and cardiac muscles and may be involved in differentiation and migration processes during myogenesis. Defects in this gene are associated with congenital myopathy. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
1181 residues, UniProt reviewed canonical sequence.
>Q13683|ITGA7
1 MAGARSRDPW GASGICYLFG SLLVELLFSR AVAFNLDVMG ALRKEGEPGS LFGFSVALHR
61 QLQPRPQSWL LVGAPQALAL PGQQANRTGG LFACPLSLEE TDCYRVDIDQ GADMQKESKE
121 NQWLGVSVRS QGPGGKIVTC AHRYEARQRV DQILETRDMI GRCFVLSQDL AIRDELDGGE
181 WKFCEGRPQG HEQFGFCQQG TAAAFSPDSH YLLFGAPGTY NWKGTARVEL CAQGSADLAH
241 LDDGPYEAGG EKEQDPRLIP VPANSYFGLL FVTNIDSSDP DQLVYKTLDP ADRLPGPAGD
301 LALNSYLGFS IDSGKGLVRA EELSFVAGAP RANHKGAVVI LRKDSASRLV PEVMLSGERL
361 TSGFGYSLAV ADLNSDGWPD LIVGAPYFFE RQEELGGAVY VYLNQGGHWA GISPLRLCGS
421 PDSMFGISLA VLGDLNQDGF PDIAVGAPFD GDGKVFIYHG SSLGVVAKPS QVLEGEAVGI
481 KSFGYSLSGS LDMDGNQYPD LLVGSLADTA VLFRARPILH VSHEVSIAPR SIDLEQPNCA
541 GGHSVCVDLR VCFSYIAVPS SYSPTVALDY VLDADTDRRL RGQVPRVTFL SRNLEEPKHQ
601 ASGTVWLKHQ HDRVCGDAMF QLQENVKDKL RAIVVTLSYS LQTPRLRRQA PGQGLPPVAP
661 ILNAHQPSTQ RAEIHFLKQG CGEDKICQSN LQLVRARFCT RVSDTEFQPL PMDVDGTTAL
721 FALSGQPVIG LELMVTNLPS DPAQPQADGD DAHEAQLLVM LPDSLHYSGV RALDPAEKPL
781 CLSNENASHV ECELGNPMKR GAQVTFYLIL STSGISIETT ELEVELLLAT ISEQELHPVS
841 ARARVFIELP LSIAGMAIPQ QLFFSGVVRG ERAMQSERDV GSKVKYEVTV SNQGQSLRTL
901 GSAFLNIMWP HEIANGKWLL YPMQVELEGG QGPGQKGLCS PRPNILHLDV DSRDRRRREL
961 EPPEQQEPGE RQEPSMSWWP VSSAEKKKNI TLDCARGTAN CVVFSCPLYS FDRAAVLHVW
1021 GRLWNSTFLE EYSAVKSLEV IVRANITVKS SIKNLMLRDA STVIPVMVYL DPMAVVAEGV
1081 PWWVILLAVL AGLLVLALLV LLLWKMGFFK RAKHPEATVP QYHAVKIPRE DRQQFKEEKT
1141 GTILRNNWGS PRREGPDAHP ILAADGHPEL GPDGHPGPGT ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ITGA7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 139 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 139 nTPM
- skeletal muscle: 136 nTPM
- blood vessel: 115 nTPM
- adipose tissue: 103 nTPM
- tongue: 78 nTPM
- smooth muscle: 77 nTPM
Single-cell type
- cardiomyocytes: 2,188 nCPM
- adipocytes: 486 nCPM
- myonuclei: 277 nCPM
- vascular smooth muscle cells: 217 nCPM
- pericytes: 179 nCPM
- astrocytes: 139 nCPM
Immune cell
- myeloid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- hippocampal formation: 42 nTPM
- cerebral cortex: 35 nTPM
- thalamus: 34 nTPM
- midbrain: 31 nTPM
- pons: 30 nTPM
- white matter: 29 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ITGA7.
Disease | AllUniProt
Conditions ITGA7 is implicated in, by any mechanism.
- Muscular dystrophy congenital due to integrin alpha-7 deficiency (MDCI) MIM:613204
Disease | GeneticClinVar
64 pathogenic / likely-pathogenic of 1,139 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital muscular dystrophy due to integrin alpha-7 deficiency
- Abnormal brain morphology
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.36
- DepMap mean gene effect
- -0.21
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell-cell adhesion
- cell-matrix adhesion
- endodermal cell differentiation
- heterotypic cell-cell adhesion
- integrin-mediated signaling pathway
- leukocyte migration
- muscle organ development
- regulation of cell shape
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Integrin alpha chain
- FG-GAP repeat
- Integrin alpha beta-propellor
- Integrin alpha, first immunoglubulin-like domain
- Integrin alpha chain, C-terminal cytoplasmic region, conserved site
- Integrin alpha, N-terminal
- Integrin domain superfamily
- Integrin alpha, second immunoglobulin-like domain
- Integrin alpha, third immunoglobulin-like domain
- FG-GAP repeat
- Integrin alpha Ig-like domain 1
- Integrin alpha Ig-like domain 2
- Integrin alpha Ig-like domain 3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ITGA7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ITGA7 as an antibody target. Whether an autoantibody or antibody against ITGA7 could matter depends on whether native ITGA7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ITGA7 is annotated at the cell surface, where native ITGA7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ITGA7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...